Prosecution Insights
Prosecution Insights
19 pending office actions • 14 art units • 18 examiners • 0 of 19 (0%) have an AI response strategy ready • 26 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 6 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 6 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (5%) |
| §101 + other | 2 (11%) |
| §103 only | 7 (37%) |
| §102 only | 2 (11%) |
| §112 only | 1 (5%) |
| Double-patenting + other | 3 (16%) |
| Multi-statute (no §101) | 3 (16%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KOMATSU, LI N | 2 | 59.6% | +71.0% |
| WHITE, DYLAN C | 1 | 77.2% | +13.0% |
| YU, LIHONG | 1 | 81.9% | +18.9% |
| BAYARD, EMMANUEL | 1 | 89.9% | +5.3% |
| UNDERDAHL, THANE E | 1 | 58.9% | +50.6% |
| KHAN, AMINA S | 1 | 47.4% | +43.4% |
| LIPPERT, JOHN WILLIAM | 1 | 56.6% | +41.3% |
| STEPHENS, AMELIA CAROLE | 1 | 80.0% | +50.0% |
| MAYHEW, BRADLEY SCOTT | 1 | — | — |
| NILAND, PATRICK DENNIS | 1 | 63.6% | -5.2% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18996419 | TRANSMISSION DEVICE AND TRANSMISSION METHOD FOR TRANSMITTING DATA BY USING CARRIER SIGNAL | BAYARD, EMMANUEL | — |
| 18564378 | PHARMACEUTICAL COMPOSITION FOR TREATING BRAIN DISEASES COMPRISING ANTIBODY SPECIFICALLY BINDING TO ASM PROTEIN AS ACTIVE INGREDIENT | STEPHENS, AMELIA CAROLE | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18020082 | PEPTIDE SELECTIVELY BINDING TO CANCER CELL-DERIVED EXOSOME, AND USES THEREOF | KONOPELSKI SNAVEL, SARA ELIZABETH | 10d overdue |
| 19085511 | SPECTRUM SHARING METHOD THROUGH FREQUENCY HOPPING IN NON-TERRESTRIAL NETWORKS ARCHITECTURE | YU, LIHONG | — |
| 18706564 | GH117A a-NEOAGAROBIOSE HYDROLASE DERIVED FROM A NOVEL AGAR-DEGRADING BACTERIUM AND PRODUCING METHOD OF L-AHG USING THE SAME | UNDERDAHL, THANE E | — |
| 18832019 | METHOD FOR PREPARING CELLULOSE-POLYVINYL ALCOHOL FABRIC WITH IMPROVED SURFACE CHARACTERISTICS, CELLULOSE-POLYVINYL ALCOHOL FABRIC WITH IMPROVED SURFACE CHARACTERISTICS PREPARED THEREBY, AND FABRIC FOR WOUND HEALING COMPRISING SAME | KHAN, AMINA S | — |
| 18286082 | COMPOUND HAVING THERMOTROPIC LIQUID CRYSTALLINE STRUCTURE, AND POLYETHYLENE GLYCOL POLYMER THEREOF | ZHANG, RUIYUN | — |
| 18022050 | COMPOSITION FOR DIAGNOSING INFECTIOUS DISEASES COMPRISING AGENT FOR MEASURING EXPRESSION LEVEL OF SREBP2 | BUCKMASTER, MARLENE VRENI | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17843418 | PD-1-DECORATED NANOCAGES AND USES THEREOF | KOMATSU, LI N | 3d overdue |
| 18138118 | FERRITIN NANOCAGE FUSED WITH PD-L1-BINDING PEPTIDE 1 AND USE THEREOF AS ANTICANCER IMMUNOTHERAPY AGENT | KOMATSU, LI N | 70d |
| 19207336 | APPARATUS AND METHOD FOR CHARGING AND DISCHARGING SCHEDULING OF ELECTRIC VEHICLE | WHITE, DYLAN C | — |
| 19085511 | SPECTRUM SHARING METHOD THROUGH FREQUENCY HOPPING IN NON-TERRESTRIAL NETWORKS ARCHITECTURE | YU, LIHONG | — |
| 18706564 | GH117A a-NEOAGAROBIOSE HYDROLASE DERIVED FROM A NOVEL AGAR-DEGRADING BACTERIUM AND PRODUCING METHOD OF L-AHG USING THE SAME | UNDERDAHL, THANE E | — |
| 18832019 | METHOD FOR PREPARING CELLULOSE-POLYVINYL ALCOHOL FABRIC WITH IMPROVED SURFACE CHARACTERISTICS, CELLULOSE-POLYVINYL ALCOHOL FABRIC WITH IMPROVED SURFACE CHARACTERISTICS PREPARED THEREBY, AND FABRIC FOR WOUND HEALING COMPRISING SAME | KHAN, AMINA S | — |
| 18295000 | NOVEL COMPOUND COMPRISING ESTER GROUP AND USES THEREOF | LIPPERT, JOHN WILLIAM | — |
| 18564378 | PHARMACEUTICAL COMPOSITION FOR TREATING BRAIN DISEASES COMPRISING ANTIBODY SPECIFICALLY BINDING TO ASM PROTEIN AS ACTIVE INGREDIENT | STEPHENS, AMELIA CAROLE | — |
| Art Unit | Apps |
|---|---|
| 1658 | 3 |
| 2633 | 1 |
| 1652 | 1 |
| 1761 | 1 |
| 1645 | 1 |
| 1621 | 1 |
| 1762 | 1 |
| 1782 | 1 |
| 1699 | 1 |
| 2872 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19207336 | APPARATUS AND METHOD FOR CHARGING AND DISCHARGING SCHEDULING OF ELECTRIC VEHICLE | WHITE, DYLAN C | — | §102 | Non-Final OA | — | Pending | May 13, 2025 |
| 19085511 | SPECTRUM SHARING METHOD THROUGH FREQUENCY HOPPING IN NON-TERRESTRIAL NETWORKS ARCHITECTURE | YU, LIHONG | — | §102§103 | Non-Final OA | — | Pending | Mar 20, 2025 |
| 18996419 | TRANSMISSION DEVICE AND TRANSMISSION METHOD FOR TRANSMITTING DATA BY USING CARRIER SIGNAL | BAYARD, EMMANUEL | 2633 | §112 | Non-Final OA | — | Pending | Jan 17, 2025 |
| 18706564 | GH117A a-NEOAGAROBIOSE HYDROLASE DERIVED FROM A NOVEL AGAR-DEGRADING BACTERIUM AND PRODUCING METHOD OF L-AHG USING THE SAME | UNDERDAHL, THANE E | 1652 | §101§102§103§112 | Non-Final OA | — | Pending | Oct 10, 2024 |
| 18832019 | METHOD FOR PREPARING CELLULOSE-POLYVINYL ALCOHOL FABRIC WITH IMPROVED SURFACE CHARACTERISTICS, CELLULOSE-POLYVINYL ALCOHOL FABRIC WITH IMPROVED SURFACE CHARACTERISTICS PREPARED THEREBY, AND FABRIC FOR WOUND HEALING COMPRISING SAME | KHAN, AMINA S | 1761 | §102§103 | Non-Final OA | — | Pending | Jul 22, 2024 |
| 18295000 | NOVEL COMPOUND COMPRISING ESTER GROUP AND USES THEREOF | LIPPERT, JOHN WILLIAM | — | §103 | Non-Final OA | — | Pending | Feb 02, 2024 |
| 18564378 | PHARMACEUTICAL COMPOSITION FOR TREATING BRAIN DISEASES COMPRISING ANTIBODY SPECIFICALLY BINDING TO ASM PROTEIN AS ACTIVE INGREDIENT | STEPHENS, AMELIA CAROLE | 1645 | §112DP | Non-Final OA | — | Pending | Nov 27, 2023 |
| 18515486 | COMPOSITION FOR INHIBITING SKIN PIGMENTATION THROUGH AUTOPHAGY ACTIVITY CONTAINING PROCYANIDIN A2 AND QUERCETIN, AS ACTIVE INGREDIENTS | MAYHEW, BRADLEY SCOTT | 1621 | §103 | Non-Final OA | — | Pending | Nov 21, 2023 |
| 18556977 | MULTIFUNCTIONAL EPOXY COMPOUND HAVING MULTIPLE LIQUID CRYSTAL CORES, AND CURED PRODUCT PRODUCED THEREFROM | NILAND, PATRICK DENNIS | 1762 | §102 | Non-Final OA | — | Pending | Oct 24, 2023 |
| 18286082 | COMPOUND HAVING THERMOTROPIC LIQUID CRYSTALLINE STRUCTURE, AND POLYETHYLENE GLYCOL POLYMER THEREOF | ZHANG, RUIYUN | 1782 | §102§103§112 | Non-Final OA | — | Pending | Oct 06, 2023 |
| 18272951 | BIOCOMPATIBLE HYDROGEL COMPRISING COMPONENT CONTAINING HYALURONIC ACID, POLYETHYLENE GLYCOL AND SILICONE | GULLEDGE, BRIAN M | 1699 | §103 | Final Rejection | 3d overdue | Pending | Jul 18, 2023 |
| 18254772 | HOLOGRAPHIC PRINTING SYSTEM AND HOLOGRAPHIC PRINTING METHOD USING SAME | CHANG, AUDREY Y | 2872 | §103 | Final Rejection | — | Pending | May 26, 2023 |
| 18138118 | FERRITIN NANOCAGE FUSED WITH PD-L1-BINDING PEPTIDE 1 AND USE THEREOF AS ANTICANCER IMMUNOTHERAPY AGENT | KOMATSU, LI N | 1658 | §103DP | Non-Final OA | 70d | Pending | Apr 23, 2023 |
| 18022050 | COMPOSITION FOR DIAGNOSING INFECTIOUS DISEASES COMPRISING AGENT FOR MEASURING EXPRESSION LEVEL OF SREBP2 | BUCKMASTER, MARLENE VRENI | 1672 | §101§112 | Final Rejection | — | Pending | Feb 17, 2023 |
| 18020082 | PEPTIDE SELECTIVELY BINDING TO CANCER CELL-DERIVED EXOSOME, AND USES THEREOF | KONOPELSKI SNAVEL, SARA ELIZABETH | 1658 | §101 | Non-Final OA | 10d overdue | Pending | Feb 07, 2023 |
| 17843418 | PD-1-DECORATED NANOCAGES AND USES THEREOF | KOMATSU, LI N | 1658 | §103 | Final Rejection | 3d overdue | Pending | Jun 17, 2022 |
| 17642250 | USE OF ENDOTHELIN RECEPTOR INHIBITOR FOR INHIBITING EXOSOME SECRETION OR INHIBITING PD-L1 EXPRESSION | BUNKER, AMY M | 1684 | §103 | Non-Final OA | — | Pending | Mar 11, 2022 |
| 17629607 | BIOCOMPATIBLE HYDROGEL COMPRISING HYALURONIC ACID AND POLYETHYLENE GLYCOL | MATTISON, LORI K | 1619 | §103DP | Non-Final OA | 96d overdue | Pending | Jan 24, 2022 |
| 17422052 | METHOD FOR SYNTHESIZING HYALURONIC ACID NANOPARTICLES, AND HYALURONIC ACID NANOPARTICLES PREPARED BY METHOD | MEJIAS, SAMANTHA LEE | 1618 | §103 | Non-Final OA | 15d overdue | Pending | Jul 09, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial